nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—Epinephrine—Dipivefrin—glaucoma	0.0873	0.226	CrCrCtD
Isoprenaline—Salbutamol—Levobunolol—glaucoma	0.0586	0.152	CrCrCtD
Isoprenaline—Salbutamol—Carteolol—glaucoma	0.0586	0.152	CrCrCtD
Isoprenaline—Pindolol—Carteolol—glaucoma	0.0501	0.13	CrCrCtD
Isoprenaline—Pindolol—Levobunolol—glaucoma	0.0501	0.13	CrCrCtD
Isoprenaline—ADRB2—Metipranolol—glaucoma	0.0479	0.108	CbGbCtD
Isoprenaline—ADRB2—Levobunolol—glaucoma	0.0479	0.108	CbGbCtD
Isoprenaline—Pindolol—Metipranolol—glaucoma	0.0478	0.124	CrCrCtD
Isoprenaline—ADRB1—Metipranolol—glaucoma	0.0472	0.106	CbGbCtD
Isoprenaline—ADRB1—Levobunolol—glaucoma	0.0472	0.106	CbGbCtD
Isoprenaline—ADRB3—Timolol—glaucoma	0.0434	0.0978	CbGbCtD
Isoprenaline—ADRB2—Carteolol—glaucoma	0.0407	0.0919	CbGbCtD
Isoprenaline—ADRB1—Carteolol—glaucoma	0.0401	0.0905	CbGbCtD
Isoprenaline—Pindolol—Betaxolol—glaucoma	0.0335	0.0867	CrCrCtD
Isoprenaline—ADRB2—Dipivefrin—glaucoma	0.029	0.0655	CbGbCtD
Isoprenaline—ADRB2—Betaxolol—glaucoma	0.0275	0.062	CbGbCtD
Isoprenaline—ADRB1—Betaxolol—glaucoma	0.0271	0.0611	CbGbCtD
Isoprenaline—ADRB2—Timolol—glaucoma	0.0177	0.04	CbGbCtD
Isoprenaline—ADRB1—Timolol—glaucoma	0.0175	0.0394	CbGbCtD
Isoprenaline—CYP1A1—Clonidine—glaucoma	0.0103	0.0232	CbGbCtD
Isoprenaline—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00126	1	CbGdCrCtD
Isoprenaline—Arrhythmia—Dipivefrin—glaucoma	0.00109	0.0149	CcSEcCtD
Isoprenaline—Convulsion—Physostigmine—glaucoma	0.00108	0.0148	CcSEcCtD
Isoprenaline—Pallor—Apraclonidine—glaucoma	0.00107	0.0146	CcSEcCtD
Isoprenaline—Pallor—Brimonidine—glaucoma	0.000917	0.0125	CcSEcCtD
Isoprenaline—Hypertension—Dipivefrin—glaucoma	0.000916	0.0125	CcSEcCtD
Isoprenaline—Tachycardia—Dipivefrin—glaucoma	0.000845	0.0116	CcSEcCtD
Isoprenaline—Vision blurred—Echothiophate—glaucoma	0.000838	0.0115	CcSEcCtD
Isoprenaline—Angina pectoris—Metipranolol—glaucoma	0.000834	0.0114	CcSEcCtD
Isoprenaline—Cardiac arrest—Levobunolol—glaucoma	0.000825	0.0113	CcSEcCtD
Isoprenaline—Bronchospasm—Carteolol—glaucoma	0.00078	0.0107	CcSEcCtD
Isoprenaline—Bronchospasm—Levobunolol—glaucoma	0.000737	0.0101	CcSEcCtD
Isoprenaline—Angina pectoris—Latanoprost—glaucoma	0.000677	0.00925	CcSEcCtD
Isoprenaline—Pallor—Clonidine—glaucoma	0.000661	0.00903	CcSEcCtD
Isoprenaline—Sweating—Carbachol—glaucoma	0.000651	0.00889	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dorzolamide—glaucoma	0.000646	0.00883	CcSEcCtD
Isoprenaline—Pulmonary oedema—Pilocarpine—glaucoma	0.000611	0.00834	CcSEcCtD
Isoprenaline—Nausea—Physostigmine—glaucoma	0.000605	0.00827	CcSEcCtD
Isoprenaline—Tension—Metipranolol—glaucoma	0.000585	0.008	CcSEcCtD
Isoprenaline—Nervousness—Metipranolol—glaucoma	0.000579	0.00792	CcSEcCtD
Isoprenaline—Arrhythmia—Carteolol—glaucoma	0.000567	0.00775	CcSEcCtD
Isoprenaline—Flushing—Carbachol—glaucoma	0.000565	0.00773	CcSEcCtD
Isoprenaline—Vision blurred—Metipranolol—glaucoma	0.000562	0.00768	CcSEcCtD
Isoprenaline—Arrhythmia—Carbachol—glaucoma	0.000544	0.00744	CcSEcCtD
Isoprenaline—Arrhythmia—Levobunolol—glaucoma	0.000536	0.00732	CcSEcCtD
Isoprenaline—Tension—Diclofenamide—glaucoma	0.000533	0.00729	CcSEcCtD
Isoprenaline—Nervousness—Diclofenamide—glaucoma	0.000528	0.00721	CcSEcCtD
Isoprenaline—Palpitations—Metipranolol—glaucoma	0.000527	0.0072	CcSEcCtD
Isoprenaline—Vision blurred—Carteolol—glaucoma	0.000521	0.00712	CcSEcCtD
Isoprenaline—Hypertension—Metipranolol—glaucoma	0.000515	0.00704	CcSEcCtD
Isoprenaline—Tremor—Diclofenamide—glaucoma	0.000509	0.00696	CcSEcCtD
Isoprenaline—Cardiac arrest—Dorzolamide—glaucoma	0.000501	0.00685	CcSEcCtD
Isoprenaline—Palpitations—Carteolol—glaucoma	0.000488	0.00667	CcSEcCtD
Isoprenaline—Palpitations—Levobunolol—glaucoma	0.000461	0.00631	CcSEcCtD
Isoprenaline—Vision blurred—Latanoprost—glaucoma	0.000456	0.00624	CcSEcCtD
Isoprenaline—Vertigo—Methazolamide—glaucoma	0.000449	0.00614	CcSEcCtD
Isoprenaline—Bronchospasm—Dorzolamide—glaucoma	0.000448	0.00612	CcSEcCtD
Isoprenaline—Angina pectoris—Dorzolamide—glaucoma	0.000444	0.00606	CcSEcCtD
Isoprenaline—Angina pectoris—Travoprost—glaucoma	0.000442	0.00604	CcSEcCtD
Isoprenaline—Angina pectoris—Brinzolamide—glaucoma	0.000436	0.00596	CcSEcCtD
Isoprenaline—Dyspnoea—Metipranolol—glaucoma	0.000434	0.00593	CcSEcCtD
Isoprenaline—Convulsion—Methazolamide—glaucoma	0.000433	0.00592	CcSEcCtD
Isoprenaline—Bronchospasm—Pilocarpine—glaucoma	0.000423	0.00579	CcSEcCtD
Isoprenaline—Hypotension—Carteolol—glaucoma	0.000421	0.00576	CcSEcCtD
Isoprenaline—Angina pectoris—Pilocarpine—glaucoma	0.000419	0.00573	CcSEcCtD
Isoprenaline—Hyperhidrosis—Carbachol—glaucoma	0.000418	0.00572	CcSEcCtD
Isoprenaline—Insomnia—Carteolol—glaucoma	0.000408	0.00557	CcSEcCtD
Isoprenaline—Hypotension—Carbachol—glaucoma	0.000404	0.00553	CcSEcCtD
Isoprenaline—Dyspnoea—Carteolol—glaucoma	0.000402	0.00549	CcSEcCtD
Isoprenaline—Hypotension—Levobunolol—glaucoma	0.000398	0.00544	CcSEcCtD
Isoprenaline—Arrhythmia—Apraclonidine—glaucoma	0.000397	0.00543	CcSEcCtD
Isoprenaline—Sweating—Dorzolamide—glaucoma	0.000389	0.00532	CcSEcCtD
Isoprenaline—Dyspnoea—Levobunolol—glaucoma	0.00038	0.00519	CcSEcCtD
Isoprenaline—Tension—Apraclonidine—glaucoma	0.00038	0.00519	CcSEcCtD
Isoprenaline—Nervousness—Apraclonidine—glaucoma	0.000376	0.00514	CcSEcCtD
Isoprenaline—Flushing—Acetazolamide—glaucoma	0.000369	0.00504	CcSEcCtD
Isoprenaline—Tension—Bimatoprost—glaucoma	0.000368	0.00503	CcSEcCtD
Isoprenaline—Sweating—Pilocarpine—glaucoma	0.000368	0.00503	CcSEcCtD
Isoprenaline—Vision blurred—Apraclonidine—glaucoma	0.000365	0.00499	CcSEcCtD
Isoprenaline—Nervousness—Bimatoprost—glaucoma	0.000365	0.00498	CcSEcCtD
Isoprenaline—Flushing—Brimonidine—glaucoma	0.000354	0.00484	CcSEcCtD
Isoprenaline—Vision blurred—Bimatoprost—glaucoma	0.000354	0.00483	CcSEcCtD
Isoprenaline—Dyspnoea—Latanoprost—glaucoma	0.000352	0.00481	CcSEcCtD
Isoprenaline—Asthenia—Metipranolol—glaucoma	0.000349	0.00477	CcSEcCtD
Isoprenaline—Pulmonary oedema—Timolol—glaucoma	0.000347	0.00474	CcSEcCtD
Isoprenaline—Palpitations—Apraclonidine—glaucoma	0.000342	0.00467	CcSEcCtD
Isoprenaline—Arrhythmia—Brimonidine—glaucoma	0.000341	0.00466	CcSEcCtD
Isoprenaline—Vertigo—Bimatoprost—glaucoma	0.000337	0.00461	CcSEcCtD
Isoprenaline—Palpitations—Bimatoprost—glaucoma	0.000332	0.00453	CcSEcCtD
Isoprenaline—Arrhythmia—Dorzolamide—glaucoma	0.000326	0.00445	CcSEcCtD
Isoprenaline—Hypertension—Bimatoprost—glaucoma	0.000324	0.00443	CcSEcCtD
Isoprenaline—Asthenia—Carteolol—glaucoma	0.000324	0.00442	CcSEcCtD
Isoprenaline—Dizziness—Metipranolol—glaucoma	0.000322	0.0044	CcSEcCtD
Isoprenaline—Arrhythmia—Brinzolamide—glaucoma	0.00032	0.00438	CcSEcCtD
Isoprenaline—Flushing—Pilocarpine—glaucoma	0.00032	0.00437	CcSEcCtD
Isoprenaline—Asthenia—Diclofenamide—glaucoma	0.000318	0.00435	CcSEcCtD
Isoprenaline—Vision blurred—Brimonidine—glaucoma	0.000313	0.00428	CcSEcCtD
Isoprenaline—Tension—Dorzolamide—glaucoma	0.000311	0.00426	CcSEcCtD
Isoprenaline—Nervousness—Dorzolamide—glaucoma	0.000308	0.00421	CcSEcCtD
Isoprenaline—Arrhythmia—Pilocarpine—glaucoma	0.000308	0.00421	CcSEcCtD
Isoprenaline—Tension—Brinzolamide—glaucoma	0.000306	0.00418	CcSEcCtD
Isoprenaline—Asthenia—Levobunolol—glaucoma	0.000306	0.00418	CcSEcCtD
Isoprenaline—Headache—Metipranolol—glaucoma	0.000305	0.00417	CcSEcCtD
Isoprenaline—Nervousness—Brinzolamide—glaucoma	0.000303	0.00414	CcSEcCtD
Isoprenaline—Convulsion—Acetazolamide—glaucoma	0.0003	0.0041	CcSEcCtD
Isoprenaline—Vision blurred—Dorzolamide—glaucoma	0.000299	0.00409	CcSEcCtD
Isoprenaline—Dizziness—Carteolol—glaucoma	0.000298	0.00408	CcSEcCtD
Isoprenaline—Vision blurred—Travoprost—glaucoma	0.000298	0.00407	CcSEcCtD
Isoprenaline—Bronchospasm—Betaxolol—glaucoma	0.000294	0.00402	CcSEcCtD
Isoprenaline—Tension—Pilocarpine—glaucoma	0.000294	0.00402	CcSEcCtD
Isoprenaline—Vision blurred—Brinzolamide—glaucoma	0.000294	0.00402	CcSEcCtD
Isoprenaline—Sweating—Clonidine—glaucoma	0.000294	0.00402	CcSEcCtD
Isoprenaline—Palpitations—Brimonidine—glaucoma	0.000294	0.00401	CcSEcCtD
Isoprenaline—Dizziness—Diclofenamide—glaucoma	0.000293	0.00401	CcSEcCtD
Isoprenaline—Asthenia—Methazolamide—glaucoma	0.000293	0.004	CcSEcCtD
Isoprenaline—Tremor—Brinzolamide—glaucoma	0.000292	0.00399	CcSEcCtD
Isoprenaline—Angina pectoris—Betaxolol—glaucoma	0.000292	0.00398	CcSEcCtD
Isoprenaline—Nervousness—Pilocarpine—glaucoma	0.000291	0.00398	CcSEcCtD
Isoprenaline—Nausea—Metipranolol—glaucoma	0.000289	0.00395	CcSEcCtD
Isoprenaline—Hypertension—Brimonidine—glaucoma	0.000287	0.00392	CcSEcCtD
Isoprenaline—Dizziness—Carbachol—glaucoma	0.000286	0.00391	CcSEcCtD
Isoprenaline—Insomnia—Apraclonidine—glaucoma	0.000286	0.0039	CcSEcCtD
Isoprenaline—Vertigo—Dorzolamide—glaucoma	0.000285	0.0039	CcSEcCtD
Isoprenaline—Vertigo—Travoprost—glaucoma	0.000284	0.00388	CcSEcCtD
Isoprenaline—Vision blurred—Pilocarpine—glaucoma	0.000283	0.00386	CcSEcCtD
Isoprenaline—Headache—Carteolol—glaucoma	0.000283	0.00386	CcSEcCtD
Isoprenaline—Dizziness—Levobunolol—glaucoma	0.000282	0.00385	CcSEcCtD
Isoprenaline—Dyspnoea—Apraclonidine—glaucoma	0.000282	0.00385	CcSEcCtD
Isoprenaline—Tremor—Pilocarpine—glaucoma	0.000281	0.00384	CcSEcCtD
Isoprenaline—Palpitations—Dorzolamide—glaucoma	0.000281	0.00383	CcSEcCtD
Isoprenaline—Vertigo—Brinzolamide—glaucoma	0.00028	0.00383	CcSEcCtD
Isoprenaline—Palpitations—Travoprost—glaucoma	0.000279	0.00382	CcSEcCtD
Isoprenaline—Headache—Diclofenamide—glaucoma	0.000278	0.0038	CcSEcCtD
Isoprenaline—Insomnia—Bimatoprost—glaucoma	0.000277	0.00379	CcSEcCtD
Isoprenaline—Palpitations—Brinzolamide—glaucoma	0.000276	0.00377	CcSEcCtD
Isoprenaline—Hypertension—Dorzolamide—glaucoma	0.000274	0.00374	CcSEcCtD
Isoprenaline—Dyspnoea—Bimatoprost—glaucoma	0.000273	0.00373	CcSEcCtD
Isoprenaline—Hypertension—Travoprost—glaucoma	0.000273	0.00373	CcSEcCtD
Isoprenaline—Headache—Carbachol—glaucoma	0.000271	0.0037	CcSEcCtD
Isoprenaline—Hypertension—Brinzolamide—glaucoma	0.000269	0.00368	CcSEcCtD
Isoprenaline—Cardiac arrest—Timolol—glaucoma	0.000269	0.00368	CcSEcCtD
Isoprenaline—Nausea—Carteolol—glaucoma	0.000268	0.00366	CcSEcCtD
Isoprenaline—Headache—Levobunolol—glaucoma	0.000267	0.00365	CcSEcCtD
Isoprenaline—Palpitations—Pilocarpine—glaucoma	0.000265	0.00362	CcSEcCtD
Isoprenaline—Tachycardia—Brimonidine—glaucoma	0.000265	0.00362	CcSEcCtD
Isoprenaline—Nausea—Diclofenamide—glaucoma	0.000263	0.0036	CcSEcCtD
Isoprenaline—Dizziness—Latanoprost—glaucoma	0.000261	0.00357	CcSEcCtD
Isoprenaline—Hypertension—Pilocarpine—glaucoma	0.000259	0.00354	CcSEcCtD
Isoprenaline—Nausea—Carbachol—glaucoma	0.000257	0.00351	CcSEcCtD
Isoprenaline—Sweating—Betaxolol—glaucoma	0.000256	0.0035	CcSEcCtD
Isoprenaline—Headache—Methazolamide—glaucoma	0.000256	0.0035	CcSEcCtD
Isoprenaline—Hypotension—Brimonidine—glaucoma	0.000253	0.00346	CcSEcCtD
Isoprenaline—Nausea—Levobunolol—glaucoma	0.000253	0.00346	CcSEcCtD
Isoprenaline—Tachycardia—Travoprost—glaucoma	0.000252	0.00344	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dorzolamide—glaucoma	0.00025	0.00342	CcSEcCtD
Isoprenaline—Tachycardia—Brinzolamide—glaucoma	0.000249	0.0034	CcSEcCtD
Isoprenaline—Headache—Latanoprost—glaucoma	0.000248	0.00338	CcSEcCtD
Isoprenaline—Arrhythmia—Clonidine—glaucoma	0.000246	0.00336	CcSEcCtD
Isoprenaline—Insomnia—Brimonidine—glaucoma	0.000245	0.00335	CcSEcCtD
Isoprenaline—Nausea—Methazolamide—glaucoma	0.000243	0.00331	CcSEcCtD
Isoprenaline—Hypotension—Dorzolamide—glaucoma	0.000242	0.00331	CcSEcCtD
Isoprenaline—Dyspnoea—Brimonidine—glaucoma	0.000242	0.0033	CcSEcCtD
Isoprenaline—Hypotension—Travoprost—glaucoma	0.000241	0.00329	CcSEcCtD
Isoprenaline—Bronchospasm—Timolol—glaucoma	0.00024	0.00329	CcSEcCtD
Isoprenaline—Tachycardia—Pilocarpine—glaucoma	0.000239	0.00326	CcSEcCtD
Isoprenaline—Angina pectoris—Timolol—glaucoma	0.000238	0.00325	CcSEcCtD
Isoprenaline—Hypotension—Brinzolamide—glaucoma	0.000238	0.00325	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pilocarpine—glaucoma	0.000237	0.00323	CcSEcCtD
Isoprenaline—Tension—Clonidine—glaucoma	0.000235	0.00321	CcSEcCtD
Isoprenaline—Insomnia—Dorzolamide—glaucoma	0.000234	0.0032	CcSEcCtD
Isoprenaline—Nervousness—Clonidine—glaucoma	0.000233	0.00318	CcSEcCtD
Isoprenaline—Dyspnoea—Dorzolamide—glaucoma	0.000231	0.00316	CcSEcCtD
Isoprenaline—Insomnia—Brinzolamide—glaucoma	0.00023	0.00315	CcSEcCtD
Isoprenaline—Dyspnoea—Travoprost—glaucoma	0.00023	0.00314	CcSEcCtD
Isoprenaline—Hypotension—Pilocarpine—glaucoma	0.000229	0.00313	CcSEcCtD
Isoprenaline—Dyspnoea—Brinzolamide—glaucoma	0.000227	0.0031	CcSEcCtD
Isoprenaline—Asthenia—Apraclonidine—glaucoma	0.000227	0.0031	CcSEcCtD
Isoprenaline—Vision blurred—Clonidine—glaucoma	0.000226	0.00308	CcSEcCtD
Isoprenaline—Tremor—Clonidine—glaucoma	0.000224	0.00307	CcSEcCtD
Isoprenaline—Flushing—Betaxolol—glaucoma	0.000222	0.00304	CcSEcCtD
Isoprenaline—Insomnia—Pilocarpine—glaucoma	0.000221	0.00303	CcSEcCtD
Isoprenaline—Asthenia—Bimatoprost—glaucoma	0.00022	0.003	CcSEcCtD
Isoprenaline—Dyspnoea—Pilocarpine—glaucoma	0.000218	0.00298	CcSEcCtD
Isoprenaline—Arrhythmia—Betaxolol—glaucoma	0.000214	0.00292	CcSEcCtD
Isoprenaline—Palpitations—Clonidine—glaucoma	0.000212	0.00289	CcSEcCtD
Isoprenaline—Sweating—Timolol—glaucoma	0.000209	0.00286	CcSEcCtD
Isoprenaline—Dizziness—Apraclonidine—glaucoma	0.000209	0.00285	CcSEcCtD
Isoprenaline—Tension—Betaxolol—glaucoma	0.000205	0.0028	CcSEcCtD
Isoprenaline—Asthenia—Acetazolamide—glaucoma	0.000203	0.00277	CcSEcCtD
Isoprenaline—Dizziness—Bimatoprost—glaucoma	0.000203	0.00277	CcSEcCtD
Isoprenaline—Nervousness—Betaxolol—glaucoma	0.000203	0.00277	CcSEcCtD
Isoprenaline—Headache—Apraclonidine—glaucoma	0.000198	0.0027	CcSEcCtD
Isoprenaline—Vision blurred—Betaxolol—glaucoma	0.000197	0.00269	CcSEcCtD
Isoprenaline—Tremor—Betaxolol—glaucoma	0.000195	0.00267	CcSEcCtD
Isoprenaline—Asthenia—Brimonidine—glaucoma	0.000195	0.00266	CcSEcCtD
Isoprenaline—Headache—Bimatoprost—glaucoma	0.000192	0.00262	CcSEcCtD
Isoprenaline—Tachycardia—Clonidine—glaucoma	0.000191	0.00261	CcSEcCtD
Isoprenaline—Hyperhidrosis—Clonidine—glaucoma	0.000189	0.00258	CcSEcCtD
Isoprenaline—Nausea—Apraclonidine—glaucoma	0.000188	0.00256	CcSEcCtD
Isoprenaline—Vertigo—Betaxolol—glaucoma	0.000187	0.00256	CcSEcCtD
Isoprenaline—Dizziness—Acetazolamide—glaucoma	0.000187	0.00255	CcSEcCtD
Isoprenaline—Asthenia—Dorzolamide—glaucoma	0.000186	0.00254	CcSEcCtD
Isoprenaline—Asthenia—Travoprost—glaucoma	0.000185	0.00253	CcSEcCtD
Isoprenaline—Palpitations—Betaxolol—glaucoma	0.000184	0.00252	CcSEcCtD
Isoprenaline—Asthenia—Brinzolamide—glaucoma	0.000183	0.0025	CcSEcCtD
Isoprenaline—Hypotension—Clonidine—glaucoma	0.000183	0.0025	CcSEcCtD
Isoprenaline—Nausea—Bimatoprost—glaucoma	0.000182	0.00249	CcSEcCtD
Isoprenaline—Dizziness—Brimonidine—glaucoma	0.000179	0.00245	CcSEcCtD
Isoprenaline—Headache—Acetazolamide—glaucoma	0.000177	0.00242	CcSEcCtD
Isoprenaline—Insomnia—Clonidine—glaucoma	0.000177	0.00242	CcSEcCtD
Isoprenaline—Asthenia—Pilocarpine—glaucoma	0.000176	0.0024	CcSEcCtD
Isoprenaline—Arrhythmia—Timolol—glaucoma	0.000175	0.00239	CcSEcCtD
Isoprenaline—Dyspnoea—Clonidine—glaucoma	0.000174	0.00238	CcSEcCtD
Isoprenaline—Dizziness—Dorzolamide—glaucoma	0.000171	0.00234	CcSEcCtD
Isoprenaline—Dizziness—Travoprost—glaucoma	0.000171	0.00233	CcSEcCtD
Isoprenaline—Headache—Brimonidine—glaucoma	0.00017	0.00232	CcSEcCtD
Isoprenaline—Dizziness—Brinzolamide—glaucoma	0.000168	0.0023	CcSEcCtD
Isoprenaline—Nausea—Acetazolamide—glaucoma	0.000168	0.00229	CcSEcCtD
Isoprenaline—Tension—Timolol—glaucoma	0.000167	0.00228	CcSEcCtD
Isoprenaline—Tachycardia—Betaxolol—glaucoma	0.000166	0.00227	CcSEcCtD
Isoprenaline—Nervousness—Timolol—glaucoma	0.000165	0.00226	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betaxolol—glaucoma	0.000165	0.00225	CcSEcCtD
Isoprenaline—Headache—Dorzolamide—glaucoma	0.000162	0.00222	CcSEcCtD
Isoprenaline—Dizziness—Pilocarpine—glaucoma	0.000162	0.00221	CcSEcCtD
Isoprenaline—Headache—Travoprost—glaucoma	0.000162	0.00221	CcSEcCtD
Isoprenaline—Nausea—Brimonidine—glaucoma	0.000161	0.0022	CcSEcCtD
Isoprenaline—Vision blurred—Timolol—glaucoma	0.000161	0.00219	CcSEcCtD
Isoprenaline—Headache—Brinzolamide—glaucoma	0.00016	0.00218	CcSEcCtD
Isoprenaline—Hypotension—Betaxolol—glaucoma	0.000159	0.00217	CcSEcCtD
Isoprenaline—Insomnia—Betaxolol—glaucoma	0.000154	0.0021	CcSEcCtD
Isoprenaline—Nausea—Dorzolamide—glaucoma	0.000154	0.0021	CcSEcCtD
Isoprenaline—Headache—Pilocarpine—glaucoma	0.000153	0.0021	CcSEcCtD
Isoprenaline—Nausea—Travoprost—glaucoma	0.000153	0.00209	CcSEcCtD
Isoprenaline—Vertigo—Timolol—glaucoma	0.000153	0.00209	CcSEcCtD
Isoprenaline—Dyspnoea—Betaxolol—glaucoma	0.000152	0.00207	CcSEcCtD
Isoprenaline—Nausea—Brinzolamide—glaucoma	0.000151	0.00207	CcSEcCtD
Isoprenaline—Palpitations—Timolol—glaucoma	0.000151	0.00206	CcSEcCtD
Isoprenaline—Hypertension—Timolol—glaucoma	0.000147	0.00201	CcSEcCtD
Isoprenaline—Nausea—Pilocarpine—glaucoma	0.000145	0.00199	CcSEcCtD
Isoprenaline—Asthenia—Clonidine—glaucoma	0.00014	0.00192	CcSEcCtD
Isoprenaline—Hyperhidrosis—Timolol—glaucoma	0.000134	0.00184	CcSEcCtD
Isoprenaline—Hypotension—Timolol—glaucoma	0.00013	0.00178	CcSEcCtD
Isoprenaline—Dizziness—Clonidine—glaucoma	0.000129	0.00177	CcSEcCtD
Isoprenaline—Insomnia—Timolol—glaucoma	0.000126	0.00172	CcSEcCtD
Isoprenaline—Dyspnoea—Timolol—glaucoma	0.000124	0.00169	CcSEcCtD
Isoprenaline—Headache—Clonidine—glaucoma	0.000122	0.00167	CcSEcCtD
Isoprenaline—Asthenia—Betaxolol—glaucoma	0.000122	0.00167	CcSEcCtD
Isoprenaline—Nausea—Clonidine—glaucoma	0.000116	0.00159	CcSEcCtD
Isoprenaline—Dizziness—Betaxolol—glaucoma	0.000113	0.00154	CcSEcCtD
Isoprenaline—Headache—Betaxolol—glaucoma	0.000107	0.00146	CcSEcCtD
Isoprenaline—Nausea—Betaxolol—glaucoma	0.000101	0.00138	CcSEcCtD
Isoprenaline—Asthenia—Timolol—glaucoma	9.98e-05	0.00136	CcSEcCtD
Isoprenaline—Dizziness—Timolol—glaucoma	9.19e-05	0.00126	CcSEcCtD
Isoprenaline—Headache—Timolol—glaucoma	8.71e-05	0.00119	CcSEcCtD
Isoprenaline—Nausea—Timolol—glaucoma	8.26e-05	0.00113	CcSEcCtD
Isoprenaline—PIK3R1—Disease—CDKN2B—glaucoma	1.06e-05	0.000111	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—SMO—glaucoma	1.06e-05	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—VEGFA—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SMO—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—C3—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CYP1B1—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ABCA1—glaucoma	1.06e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NGFR—glaucoma	1.05e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—GSTM1—glaucoma	1.04e-05	0.000109	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—SMO—glaucoma	1.04e-05	0.000108	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.04e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NGFR—glaucoma	1.03e-05	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—BAD—glaucoma	1.03e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—C3—glaucoma	1.03e-05	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—APOE—glaucoma	1.02e-05	0.000107	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—BAD—glaucoma	1.02e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NGF—glaucoma	1.02e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CAV1—glaucoma	1.02e-05	0.000106	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—APOE—glaucoma	1.01e-05	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CDKN1B—glaucoma	1e-05	0.000104	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CA1—glaucoma	1e-05	0.000104	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP9—glaucoma	1e-05	0.000104	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CAV1—glaucoma	1e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NTRK1—glaucoma	9.98e-06	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NTRK2—glaucoma	9.92e-06	0.000103	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NTRK1—glaucoma	9.83e-06	0.000102	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—BAD—glaucoma	9.78e-06	0.000102	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RPTOR—glaucoma	9.75e-06	0.000102	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CTSA—glaucoma	9.7e-06	0.000101	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NTRK2—glaucoma	9.68e-06	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—C3—glaucoma	9.67e-06	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—C3—glaucoma	9.66e-06	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—NOS3—glaucoma	9.63e-06	0.0001	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CDKN1B—glaucoma	9.62e-06	0.0001	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—BAD—glaucoma	9.55e-06	9.95e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RPTOR—glaucoma	9.54e-06	9.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP2—glaucoma	9.5e-06	9.9e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NCK2—glaucoma	9.44e-06	9.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HDAC9—glaucoma	9.42e-06	9.81e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—BAD—glaucoma	9.41e-06	9.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—VEGFA—glaucoma	9.26e-06	9.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—BCL2L1—glaucoma	9.25e-06	9.63e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NCK2—glaucoma	9.24e-06	9.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—MTHFR—glaucoma	9.22e-06	9.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CDKN2B—glaucoma	9.2e-06	9.58e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CA2—glaucoma	9.16e-06	9.54e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CDKN2B—glaucoma	9.06e-06	9.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CDKN1B—glaucoma	9.04e-06	9.41e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—CDKN2A—glaucoma	9.02e-06	9.39e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—APOE—glaucoma	9e-06	9.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—VEGFA—glaucoma	8.99e-06	9.36e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.95e-06	9.32e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.95e-06	9.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CAV1—glaucoma	8.92e-06	9.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MTHFR—glaucoma	8.92e-06	9.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EDN1—glaucoma	8.82e-06	9.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PTGS2—glaucoma	8.81e-06	9.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—NOS3—glaucoma	8.73e-06	9.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EDN1—glaucoma	8.69e-06	9.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—glaucoma	8.63e-06	8.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—APOE—glaucoma	8.58e-06	8.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NGFR—glaucoma	8.51e-06	8.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—CAV1—glaucoma	8.5e-06	8.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FN1—glaucoma	8.49e-06	8.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GSTM1—glaucoma	8.45e-06	8.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—BAD—glaucoma	8.39e-06	8.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—BAD—glaucoma	8.38e-06	8.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CDKN1B—glaucoma	8.34e-06	8.69e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NGFR—glaucoma	8.3e-06	8.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—APOE—glaucoma	8.3e-06	8.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CAV1—glaucoma	8.23e-06	8.57e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EDN1—glaucoma	8.23e-06	8.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NGF—glaucoma	8.11e-06	8.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NTRK1—glaucoma	8.08e-06	8.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—NOS3—glaucoma	8.07e-06	8.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—CDKN2A—glaucoma	8.06e-06	8.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HDAC9—glaucoma	8.03e-06	8.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—glaucoma	8e-06	8.33e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NGF—glaucoma	7.99e-06	8.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.98e-06	8.32e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NTRK1—glaucoma	7.89e-06	8.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HDAC9—glaucoma	7.85e-06	8.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—BAD—glaucoma	7.74e-06	8.06e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—EDN1—glaucoma	7.72e-06	8.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—C3—glaucoma	7.71e-06	8.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NOS3—glaucoma	7.68e-06	8e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—C3—glaucoma	7.59e-06	7.91e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NOS3—glaucoma	7.56e-06	7.88e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—EDN1—glaucoma	7.55e-06	7.87e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1A—glaucoma	7.47e-06	7.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MTHFR—glaucoma	7.47e-06	7.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CDKN2B—glaucoma	7.45e-06	7.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PTGS2—glaucoma	7.38e-06	7.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SMO—glaucoma	7.37e-06	7.68e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CDKN2B—glaucoma	7.27e-06	7.57e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN2B—glaucoma	7.23e-06	7.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CDKN1B—glaucoma	7.2e-06	7.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—C3—glaucoma	7.19e-06	7.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—APOE—glaucoma	7.18e-06	7.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EDN1—glaucoma	7.15e-06	7.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP9—glaucoma	7.14e-06	7.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—CDKN1B—glaucoma	7.14e-06	7.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CAV1—glaucoma	7.11e-06	7.41e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CDKN1B—glaucoma	7.1e-06	7.39e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—APOE—glaucoma	7.07e-06	7.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTGS2—glaucoma	7.02e-06	7.31e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EDN1—glaucoma	7.01e-06	7.3e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CAV1—glaucoma	7e-06	7.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—glaucoma	6.99e-06	7.28e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EDN1—glaucoma	6.98e-06	7.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—APOE—glaucoma	6.95e-06	7.24e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTGS2—glaucoma	6.92e-06	7.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CAV1—glaucoma	6.89e-06	7.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EDN1—glaucoma	6.86e-06	7.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CDKN1B—glaucoma	6.81e-06	7.09e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FN1—glaucoma	6.77e-06	7.05e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—C3—glaucoma	6.74e-06	7.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NOS3—glaucoma	6.74e-06	7.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK2—glaucoma	6.74e-06	7.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—BAD—glaucoma	6.69e-06	6.96e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FN1—glaucoma	6.67e-06	6.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CDKN1B—glaucoma	6.65e-06	6.93e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—C3—glaucoma	6.6e-06	6.87e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—BAD—glaucoma	6.59e-06	6.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NGF—glaucoma	6.57e-06	6.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—C3—glaucoma	6.57e-06	6.84e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CDKN1B—glaucoma	6.55e-06	6.82e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TXN—glaucoma	6.45e-06	6.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—NOS3—glaucoma	6.43e-06	6.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—glaucoma	6.41e-06	6.68e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NGF—glaucoma	6.41e-06	6.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—glaucoma	6.29e-06	6.55e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BCL2L1—glaucoma	6.29e-06	6.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SMO—glaucoma	6.28e-06	6.54e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—C3—glaucoma	6.25e-06	6.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS3—glaucoma	6.22e-06	6.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SMO—glaucoma	6.14e-06	6.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—C3—glaucoma	6.12e-06	6.38e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—C3—glaucoma	6.1e-06	6.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MTHFR—glaucoma	6.06e-06	6.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—C3—glaucoma	5.99e-06	6.24e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.89e-06	6.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTGS2—glaucoma	5.88e-06	6.12e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CDKN1B—glaucoma	5.84e-06	6.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CDKN1B—glaucoma	5.84e-06	6.08e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.83e-06	6.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOE—glaucoma	5.81e-06	6.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NGFR—glaucoma	5.78e-06	6.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CAV1—glaucoma	5.76e-06	6e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK2—glaucoma	5.75e-06	5.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BAD—glaucoma	5.7e-06	5.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—glaucoma	5.69e-06	5.93e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOE—glaucoma	5.67e-06	5.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOE—glaucoma	5.64e-06	5.88e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CAV1—glaucoma	5.62e-06	5.86e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK2—glaucoma	5.62e-06	5.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CAV1—glaucoma	5.59e-06	5.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—glaucoma	5.5e-06	5.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NTRK1—glaucoma	5.5e-06	5.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FN1—glaucoma	5.48e-06	5.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—BAD—glaucoma	5.42e-06	5.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—glaucoma	5.41e-06	5.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CDKN1B—glaucoma	5.39e-06	5.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NOS3—glaucoma	5.38e-06	5.6e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FN1—glaucoma	5.35e-06	5.57e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NOS3—glaucoma	5.3e-06	5.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—BAD—glaucoma	5.29e-06	5.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—BAD—glaucoma	5.26e-06	5.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—NOS3—glaucoma	5.21e-06	5.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN2B—glaucoma	5.06e-06	5.27e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTT1—glaucoma	5e-06	5.21e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGFR—glaucoma	4.93e-06	5.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EDN1—glaucoma	4.86e-06	5.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—glaucoma	4.86e-06	5.06e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGFR—glaucoma	4.82e-06	5.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—glaucoma	4.76e-06	4.96e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—glaucoma	4.75e-06	4.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NTRK1—glaucoma	4.68e-06	4.88e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CDKN1B—glaucoma	4.66e-06	4.85e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CDKN1B—glaucoma	4.59e-06	4.78e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NTRK1—glaucoma	4.58e-06	4.77e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—glaucoma	4.49e-06	4.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NGF—glaucoma	4.47e-06	4.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—glaucoma	4.36e-06	4.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN2B—glaucoma	4.32e-06	4.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—glaucoma	4.31e-06	4.49e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—glaucoma	4.25e-06	4.43e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—glaucoma	4.25e-06	4.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C3—glaucoma	4.25e-06	4.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—glaucoma	4.23e-06	4.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN2B—glaucoma	4.22e-06	4.4e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—glaucoma	4.14e-06	4.31e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—glaucoma	4.05e-06	4.22e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.03e-06	4.2e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCA1—glaucoma	3.99e-06	4.15e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP1B1—glaucoma	3.99e-06	4.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CDKN1B—glaucoma	3.97e-06	4.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—glaucoma	3.95e-06	4.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CAV1—glaucoma	3.92e-06	4.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—glaucoma	3.87e-06	4.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—glaucoma	3.87e-06	4.03e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—glaucoma	3.82e-06	3.97e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NGF—glaucoma	3.81e-06	3.96e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CDKN1B—glaucoma	3.77e-06	3.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FN1—glaucoma	3.73e-06	3.88e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NGF—glaucoma	3.72e-06	3.88e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—BAD—glaucoma	3.68e-06	3.84e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CDKN1B—glaucoma	3.68e-06	3.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—glaucoma	3.67e-06	3.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN1B—glaucoma	3.66e-06	3.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—glaucoma	3.62e-06	3.77e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—glaucoma	3.54e-06	3.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—glaucoma	3.49e-06	3.64e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—glaucoma	3.41e-06	3.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—glaucoma	3.37e-06	3.51e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CAV1—glaucoma	3.34e-06	3.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—glaucoma	3.29e-06	3.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CAV1—glaucoma	3.26e-06	3.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—glaucoma	3.19e-06	3.32e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FN1—glaucoma	3.18e-06	3.31e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BAD—glaucoma	3.14e-06	3.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—glaucoma	3.14e-06	3.27e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FN1—glaucoma	3.11e-06	3.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BAD—glaucoma	3.07e-06	3.2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—glaucoma	3.06e-06	3.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—glaucoma	2.96e-06	3.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—glaucoma	2.93e-06	3.05e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—glaucoma	2.88e-06	3e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—glaucoma	2.82e-06	2.93e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—glaucoma	2.62e-06	2.73e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAV1—glaucoma	2.6e-06	2.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1B—glaucoma	2.56e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—glaucoma	2.52e-06	2.63e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—glaucoma	2.47e-06	2.57e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—glaucoma	2.38e-06	2.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—glaucoma	2.37e-06	2.47e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—glaucoma	2.31e-06	2.41e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1B—glaucoma	2.19e-06	2.28e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1B—glaucoma	2.14e-06	2.23e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—glaucoma	2.13e-06	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—glaucoma	2.02e-06	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—glaucoma	1.98e-06	2.06e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—glaucoma	1.96e-06	2.05e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—glaucoma	1.82e-06	1.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—glaucoma	1.8e-06	1.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—glaucoma	1.78e-06	1.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—glaucoma	1.61e-06	1.68e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—glaucoma	1.37e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—glaucoma	1.34e-06	1.4e-05	CbGpPWpGaD
